
|Videos|March 19, 2021
Dr. Richard Lee on why it’s “a wonderful time” for BPH treatment
Author(s)Urology Times staff
“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.
Advertisement
In this interview, Richard K. Lee, MD, MBA, discusses the recent paper European Urology Focus paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study launches of MRI plus PSMA-PET imaging for prostate cancer detection
2
New Data Influencing your Treatment Decisions in mCSPC
3
Initial ARID results published in World Journal of Urology as pivotal trial progresses
4
Wesley Chou, MD, shares early insights into gene expression changes in treated RCC
5



















